Very recently, it was demonstrated that RUNX2 was highly expressed in adherent B-NHL and MM cell lines compared to cells grown in suspension and that knocking down the expression of RUNX2 could overcome cell-adhesion-mediated drug resistance [62]. Here, RUNX2 is linked to Miyoshi myopathy.